You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDC

Showing 26 - 50 of 3,393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antibiotic Side Effect, Behavioral Changes Trial in Murray (CDC Core Elements of Outpatient Stewardship)

Recruiting
  • Antibiotic Side Effect
  • Behavioral Changes
  • CDC Core Elements of Outpatient Stewardship
  • Murray, Utah
    Intermountain Medical Center
Mar 28, 2022

Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 12, 2022

Anemia, Menstrual Hygiene Management, Improved Water, Sanitation and Hygiene (WASH) Trial in Ottawa (dietary supplement,

Completed
  • Anemia
  • +2 more
  • Weekly Iron and Folic Acid Supplementation (WIFA)
  • +4 more
  • Ottawa, Ontario, Canada
    Nutrition International
Jul 8, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Syphilis Trial in United States (Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum, Aptima

Recruiting
  • Syphilis
  • Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
  • +2 more
  • Los Angeles, California
  • +8 more
Oct 9, 2023

World Trade Center Particulate Matter Induced Cardiorespiratory

Not yet recruiting
  • Cardiorespiratory and Vascular Dysfunction
  • Obstructive Airway Disease
    • New York, New York
      NYU Clinical & Translational Science Institute Clinical Research
    Jan 18, 2022

    Dilated Cardiomyopathy Trial in Okayama (CDC infusion)

    Completed
    Has Results
    • Dilated Cardiomyopathy
    • CDC infusion
    • Okayama, Japan
      Okayama University Hospital
    Nov 23, 2021

    Vaccine Refusal Trial in Shanghai (Broadened information about cancers, Information about STDs, Information about infectious

    Active, not recruiting
    Has Results
    • Vaccine Refusal
    • Broadened information about cancers
    • +7 more
    • Shanghai, China
      Shanghai CDC
    Jan 29, 2022

    Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 25, 2022

    Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

    Completed
    • Grade 3a Follicular Lymphoma
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)

    Recruiting
    • Smoldering Plasma Cell Myeloma
    • Biopsy Specimen Radiography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 12, 2021

    Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • Plasma Cell Myeloma
    • Ixazomib Citrate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2022

    Fatigue, Sleep Trial in Pittsburgh (SaFTiE, Attention Placebo Control)

    Recruiting
    • Fatigue
    • Sleep
    • SaFTiE
    • Attention Placebo Control
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Sep 17, 2021

    Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

    Active, not recruiting
    • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Incomplete Freund's Adjuvant
    • +4 more
    • Buffalo, New York
    • +1 more
    Dec 12, 2022

    Disorders and Lung Cancer in Benzene-Exposed Workers in China

    Completed
    • Lung Cancer
    • +4 more
      • Beijing, China
        China Center for Disease Control (CDC)
      May 11, 2021

      Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint

      Withdrawn
      • Non Small Cell Lung Cancer
      • This is a non-interventional study
      • Grenoble, Isère, France
        CHU Grenoble-Alpes
      Mar 26, 2021

      Airway Disease, Barrett's and Underdiagnosed Reflux

      Not yet recruiting
      • Airway Disease
      • +2 more
        • New York, New York
          NYU Clinical & Translational Science Institute Clinical Research
        Jan 18, 2022

        HIV CDC Category A1 Trial in Phalombe (Mzake ndi Mzake T1, Mzake ndi Mzake T2, Mzake ndi Mzake T3)

        Completed
        • HIV CDC Category A1
        • Mzake ndi Mzake T1
        • +2 more
        • Phalombe, Malawi
          Phalombe district communitie
        Nov 11, 2021

        Rapid Non-clinical Screening Tests for Early Detection of

        Completed
        • Periodontitis
        • Gingivitis
        • Bleeding on brushing
        • Hong Kong, China
          Prince Philip Dental Hospital, the Univerisity of Hong Kong
        Jan 9, 2022

        Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

        Active, not recruiting
        • Hematopoietic Cell Transplantation Recipient
        • Plasma Cell Myeloma
        • Elotuzumab
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 2, 2022

        Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

        Active, not recruiting
        • Recurrent Plasma Cell Myeloma
        • Jacksonville, Florida
          Mayo Clinic in Florida
        Jan 4, 2023

        Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

        Not yet recruiting
        • Follicular Lymphoma
        • Biospecimen Collection
        • +7 more
        • Duarte, California
        • +1 more
        Oct 27, 2023

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,

        Completed
        Has Results
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Laboratory Biomarker Analysis
        • +2 more
        • Rochester, Minnesota
          Mayo Clinic
        Dec 1, 2021

        Life Style Trial in Aurora (Health Links + Leadership Training, Health Links)

        Completed
        • Life Style
        • Health Links + Leadership Training
        • Health Links
        • Aurora, Colorado
          University of Colorado Anschutz Medical Campus
        Jul 15, 2021